The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Gritstone bio Inc. (GRTS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.10, or -2.90%, to $3.35. The Gritstone bio Inc. has recorded 3,091 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $3.45 and fluctuated between $3.4950 as its day high and $3.1950 as its day low. The current market capitalization of Gritstone bio Inc. is $272.58M. A total of 1.0 million shares were traded on the day, compared to an average of 1.15M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, GRTS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 7 BUYs and 0 SELLs from insiders. Insiders purchased 193,021 shares during that period but sold 0.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for GRTS in the last 3 months, the mean price target is $8.75 with high estimates of $20.00 and low estimates of $2.00. In terms of 52-week highs and lows, GRTS has a high of $13.45 and a low of $1.71.
As of this writing, GRTS has an earnings estimate of -$0.41 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.44. The company reported an EPS of -$0.34 in the last quarter, which was 8.10% higher than expectations of -$0.37.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 5 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GRTS is Overweight with a score of 4.00. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.